human
coronaviru
one
main
circul
hcov
worldwid
caus
respiratori
tract
ill
like
runni
nose
cough
bronchiol
pneumonia
recent
sever
respiratori
ill
outbreak
report
longterm
care
facil
sambucu
formosananakai
speci
elderberri
tradit
medicin
herb
antiinflammatori
antivir
potenti
studi
investig
antivir
activ
sambucu
formosananakai
stem
ethanol
extract
phenol
acid
constitu
extract
less
cytotox
concentrationdepend
increas
activ
includ
cytopath
fraction
viru
yield
plaqu
format
viru
attach
among
phenol
acid
constitu
sambucu
formosananakai
extract
caffeic
acid
chlorogen
acid
gallic
acid
sustain
activ
rank
follow
order
viru
yield
reduct
caffeic
acid
ic
chlorogen
acid
ic
coumar
acid
ic
caffeic
acid
significantli
inhibit
replic
celltyp
independ
manner
specif
block
viru
attach
ic
therefor
result
reveal
sambucu
formosana
nakai
stem
ethanol
extract
display
strong
potenti
caffeic
acid
could
vital
compon
activ
find
could
help
develop
antivir
human
coronaviru
hcov
member
genu
alphacoronaviru
coronavirida
famili
one
common
human
coronavirus
li
lin
huang
et
al
genom
positivestrand
rna
near
kb
nucleotid
contain
untransl
region
utr
spike
envelop
e
membran
nucleoprotein
n
geng
et
al
encod
overlap
replicas
via
ribosom
frameshift
nucleotid
papainlik
plpro
proteas
embed
within
replicas
process
cisand
transcleavag
activ
divid
replicas
nonstructur
protein
nsp
modul
viral
rna
replic
among
common
human
coronavirus
like
one
main
circul
hcov
fall
winter
worldwid
caus
mild
upper
respiratori
tract
ill
like
runni
nose
cough
sore
throat
young
children
young
adult
elderli
cui
et
al
dijkman
et
al
interestingli
frequent
detect
hcov
influenza
virus
rhinoviru
specimen
young
adult
acut
respiratori
infect
cough
bodi
ach
chill
feverfeverish
davi
et
al
importantli
also
associ
lower
respiratori
tract
ill
pneumonia
bronchiol
young
children
elderli
huang
http
huang
http
receiv
june
receiv
revis
form
septemb
accept
septemb
et
al
infect
high
preval
hospit
patient
pneumonia
winter
recent
sever
respiratori
ill
outbreak
longterm
care
facil
louisiana
report
associ
infect
winter
hand
et
al
among
case
age
patient
pneumonia
hospit
patient
dead
moreov
screen
children
acut
undifferenti
febril
ill
rural
haiti
indic
identifi
blood
sampl
four
patient
age
year
respiratori
symptom
two
case
headach
other
exhibit
influenza
viru
caus
abdomin
symptom
beau
de
rochar
et
al
therefor
notabl
pathogen
etiolog
mild
sever
respiratori
diseas
even
acut
undifferenti
febril
ill
sambucu
formosananakai
also
known
sambucu
chinensi
lindl
sambucu
javanica
speci
elderberri
belong
famili
adoxacea
grow
subtrop
tropic
asian
area
includ
taiwan
china
japan
cambodia
india
etc
lin
tome
yang
chiu
hong
et
al
sambucu
formosananakai
tradit
medicin
herb
taiwan
reduc
inflamm
enhanc
circul
treat
rheumatoid
low
back
pain
neuriti
dermat
infect
diseas
yang
chiu
chemic
compon
sambucu
formosananakai
includ
sambuculin
oleanol
acid
ursol
acid
pomol
acid
lupeol
palmit
glycyrrhet
acid
phenol
acid
constitu
flavonoid
chen
et
al
chen
et
al
liao
et
al
lin
tome
yang
lin
zhang
et
al
addit
phenol
acid
constitu
sambucu
formosananakai
includ
caffeic
acid
caffeotann
acid
chlorogen
acid
coumar
acid
ferul
acid
gallic
acid
identifi
member
import
activ
compon
antiinflammatori
antitumor
antihepatotox
activ
chen
et
al
liao
et
al
yang
lin
zhang
et
al
activ
compon
sambucu
formosananakai
similar
sambucu
speci
includ
sambucu
nigra
l
sambucu
lanceolata
process
antioxid
antirad
antivir
antimicrobi
antiinflammatori
activ
barak
et
al
krawitz
et
al
mandron
et
al
pinto
et
al
pliszka
porter
bode
turek
cisowski
especi
extract
sambucu
nigra
l
exert
antivir
activ
influenza
b
virus
human
immunodefici
viru
herp
simplex
viru
type
krawitz
et
al
serkedjieva
et
al
zakayron
et
al
amoro
et
al
mahmood
et
al
roschek
et
al
sambucu
nigraphenol
acid
like
caffeic
acid
show
highli
inhibitori
effect
vitro
replic
influenza
viru
porter
bode
utsunomiya
et
al
sinc
sambucu
formosananakai
contain
antivir
activ
compon
extract
sambucu
nigra
l
antivir
activ
sambucu
formosananakai
worthi
investig
studi
explor
activ
sambucu
formosananakai
stem
ethanol
extract
marker
phenol
acid
constitu
like
caffeic
acid
chlorogen
acid
coumar
acid
ferul
acid
gallic
acid
studi
indic
inhibitori
activ
sambucu
formosananakai
extract
phenol
acid
constitu
induc
cytopath
effect
viru
yield
earli
stage
replic
concentrationdepend
celltyp
independ
manner
provid
dr
lia
van
der
hoek
academ
medic
center
netherland
amplifi
cell
describ
prior
studi
cell
cultur
minimum
essenti
medium
mem
contain
mm
lglutamin
penicillin
streptomycin
fetal
bovin
serum
fb
co
incub
cell
use
perform
antivir
assay
examin
antivir
mechan
human
airway
cell
cultur
mem
supplement
fb
antibiot
mention
maintain
confluent
also
use
confirm
antivir
activ
indic
phenol
acid
constitu
dri
stem
sambucu
formosana
nakai
supplement
fig
purchas
medicin
herb
pharmaci
taichung
identifi
describ
flora
taiwan
yang
chiu
dri
stem
slice
supplement
fig
soak
ethanol
sonic
h
stem
ethanol
extract
filter
whatman
paper
lyophil
iwaki
p
freez
dryer
describ
previou
studi
wang
et
al
powder
sambucu
formosana
nakai
stem
ethanol
extract
kept
steril
bottl
stock
solut
mgml
dimethyl
sulfoxid
prepar
store
freezer
test
solut
stem
extract
dilut
media
phenol
acid
constitu
caffeic
acid
chlorogen
acid
coumar
acid
ferul
acid
gallic
acid
purchas
sigmaaldrich
compani
cell
cellswel
cultur
plate
overnight
quintupl
treat
sambucu
formosana
nakai
stem
ethanol
extract
phenol
acid
constitu
caffeic
acid
chlorogen
acid
coumar
acid
ferul
acid
gallic
acid
day
incub
mgml
bromid
mtt
addit
h
cell
lysi
isopropanol
yield
absorb
od
wavelength
nm
nm
assess
use
microelisa
reader
cell
viabil
cytotox
concentr
show
toxic
effect
cc
subsequ
determin
previous
describ
wang
et
al
cell
cellswel
cultur
plate
overnight
infect
pfu
plaqu
format
unit
repres
moi
multipl
infect
significantli
induc
viral
cytopath
effect
cpe
cell
simultan
ad
hcov
treat
sambucu
formosana
nakai
stem
ethanol
extract
concentr
phenol
acid
constitu
concentr
respect
incub
co
hcov
cytopath
effect
cpe
cell
swell
round
vacuol
eventu
detach
photograph
use
microscop
vacuol
cpe
hcov
cell
predomin
lednicki
et
al
cell
cycl
assay
cell
harvest
h
post
infect
stain
propidium
iodid
examin
use
flow
cytometri
describ
prior
studi
determin
product
progeni
virion
viru
yield
assay
cultur
media
collect
determin
viru
titer
use
plaqu
assay
cell
monolay
well
plate
ad
serial
dilut
cultur
media
incub
cell
monolay
overlaid
medium
contain
agaros
ml
per
well
incub
co
incub
allow
plaqu
format
final
cell
monolay
stain
solut
naphthol
blueblack
dye
plaqu
number
calcul
fifti
percent
inhibitori
concentr
ic
viru
yield
reduct
stem
ethanol
extract
phenol
acid
constitu
determin
plaqu
format
inhibit
assay
cell
monolay
cultur
plate
infect
pfu
maximum
number
plaqu
count
well
plate
addit
hcov
cell
immedi
treat
ethanol
extract
concentr
caffeic
acid
chlorogen
acid
concentr
respect
incub
co
incub
mixtur
remov
well
cell
monolay
cultur
medium
contain
agaros
perform
plaqu
assay
mention
virucid
assay
pfu
ad
eppendorf
tube
directli
treat
ethanol
extract
caffeic
acid
chlorogen
acid
h
minim
antivir
effect
indic
agent
cell
near
pfu
dilut
mixtur
viru
extract
phenol
acid
ad
cell
monolay
plate
determin
residu
viral
infect
use
plaqu
assay
describ
virucid
activ
calcul
base
comparison
residu
infect
treat
group
untreat
group
attach
assay
cell
monolay
plate
place
h
infect
pfu
immedi
ad
ethanol
extract
caffeic
acid
chlorogen
acid
addit
incub
mixtur
viru
extract
phenol
acid
remov
well
cell
monolay
overlaid
mem
medium
agaros
co
incub
execut
plaqu
assay
mention
attach
inhibit
analyz
accord
ratio
plaqu
number
treat
group
untreat
group
measur
inhibitori
activ
caffeic
acid
replic
human
airway
epitheli
cell
cell
cellswel
cultur
plate
overnight
infect
pfu
moi
addit
hcov
cell
simultan
treat
caffeic
acid
concentr
incub
co
incub
swell
round
eventu
deattach
cpe
predomin
lednicki
et
al
imag
record
microscop
subsequ
cell
fix
paraformaldehyd
solut
pb
min
incub
quench
buffer
mm
nh
ci
min
permeabil
block
use
cell
perfor
block
solut
contain
albumin
bovin
affymetrix
plu
triton
thermofish
h
react
sera
bsa
overnight
secondari
antibodi
alexa
fluor
antimous
igg
bsa
h
thermofish
stain
dapi
thermofish
min
room
temperatur
imag
mock
infect
infectedtr
cell
photograph
use
fluoresc
microscopi
infect
repres
ratio
red
fluoresc
signal
cell
blue
fluoresc
signal
total
nucleus
calcul
imag
j
p
valu
calcul
base
anova
use
spss
program
student
ttest
data
three
independ
experi
p
valu
less
result
assay
statist
signific
sambucu
formosana
nakai
stem
ethanol
extract
low
cytotox
cc
valu
cell
supplement
fig
tabl
subsequ
abil
stem
ethanol
extract
assess
cytopath
cell
cycl
viru
yield
assay
fig
sambucu
formosana
nakai
extract
concentrationdepend
reduc
cytopath
infect
cell
fig
vacuol
infect
cell
appear
predominantli
describ
prior
report
lednicki
et
al
extract
also
significantli
decreas
fraction
infect
cell
fig
addit
sambucu
formosananakai
extract
inhibit
vitro
product
progeni
concentrationdepend
manner
plaqu
assay
indic
ic
valu
sambucu
formosananakai
extract
viru
yield
fig
remark
result
demonstr
sambucu
formosananakai
stem
ethanol
extract
serv
significantli
antivir
activ
discov
inhibitori
action
sambucu
formosananakai
extract
stage
replic
plaqu
format
virucid
activ
viru
attach
assay
perform
use
plaqu
assay
fig
tabl
sambucu
formosananakai
extract
meaning
inhibit
plaqu
format
ic
valu
fig
virucid
assay
sambucu
formosananakai
extract
slight
virucid
activ
lower
inhibit
interfer
particl
infect
compar
mock
control
fig
viru
attach
assay
sambucu
formosananakai
extract
concentrationdepend
reduc
attach
onto
cell
monolay
plate
incub
result
demonstr
ethanol
extract
influenti
inhibitori
effect
attach
ic
valu
fig
result
demonstr
sambucu
formosananakai
extract
specif
suppress
viral
plaqu
format
viru
attach
replic
phenol
acid
constitu
rich
extract
sambucu
nakai
extract
less
cytotox
cell
cc
valu
caffeic
acid
chlorogen
acid
gallic
acid
greater
supplement
fig
tabl
inhibitori
assay
induc
cytopath
effect
caffeic
acid
chlorogen
acid
gallic
acid
coumar
acid
ferul
acid
diminish
cytopath
infect
cell
fig
antivir
activ
phenol
acid
constitu
vitro
product
rank
follow
order
viru
yield
reduct
caffeic
acid
ic
chlorogen
acid
ic
coumar
acid
ic
fig
tabl
result
verifi
phenol
acid
constitu
like
caffeic
acid
chlorogen
acid
gallic
acid
exhibit
promin
antivir
activ
potenti
compon
sambucu
formosananakai
extract
examin
antivir
mechan
caffeic
acid
chlorogen
acid
assay
plaqu
format
virucid
activ
viru
attach
subsequ
perform
fig
tabl
caffeic
acid
stronger
inhibitori
activ
plaqu
format
chlorogen
acid
valu
plaqu
format
caffeic
acid
chlorogen
acid
respect
fig
caffeic
acid
chlorogen
acid
concentrationdepend
serv
virucid
activ
ic
power
reduc
attach
fig
effect
sambucu
formosana
nakai
extract
plaqu
format
virucid
activ
viru
attach
cell
monolay
infect
simultan
treat
extract
h
cover
agaros
overlay
medium
incub
co
incub
plaqu
determin
crystal
violet
stain
inhibitori
activ
extract
plaqu
format
accord
ratio
loss
plaqu
number
mocktreat
group
virucid
assay
extract
mix
pfu
incub
h
extractviru
mixtur
dilut
dilut
examin
residu
infect
plaqu
assay
b
attach
assay
mix
extract
immedi
ad
onto
cell
monolay
h
wash
cell
monolay
overlaid
agaros
medium
day
co
incub
attach
inhibit
determin
base
residu
plaqu
c
p
valu
p
valu
compar
mocktreat
cell
fig
inhibitori
effect
phenol
acid
constitu
viral
cytopath
viru
yield
infect
cell
moi
ad
cell
cultur
immedi
treat
phenol
acid
constitu
virusinduc
cytopath
effect
photograph
h
postinfect
microscopi
supernat
cell
harvest
hpi
viru
yield
supernat
determin
plaqu
assay
rate
viru
yield
reduct
calcul
base
ratio
loss
particl
number
mocktreat
group
b
ca
caffeic
acid
ch
chlorogen
acid
co
coumar
acid
fe
ferul
acid
ga
gallic
acid
p
valu
p
valu
compar
mocktreat
infect
cell
cell
surfac
ic
respect
fig
addit
infect
inhibit
assay
human
airway
epithelia
cell
perform
cell
moi
treat
caffeic
acid
incub
microscop
photographi
indic
swell
round
observ
cell
fig
top
describ
previou
studi
lednicki
et
al
caffeic
acid
significantli
lessen
viral
cpe
fig
top
immunofluoresc
stain
demonstr
caffeic
acid
concentrationdepend
reduc
infect
determin
accord
ratio
cell
total
cell
stain
dapi
fig
middl
bottom
inhibitori
assay
immunofluoresc
stain
infect
indic
caffeic
acid
potent
antivir
activ
replic
cell
ic
fig
result
reveal
caffeic
acid
display
potent
activ
celltyp
independ
manner
specif
inhibit
attach
stage
replic
studi
first
report
antivir
efficaci
sambucu
formosananakai
extract
relat
phenol
acid
constitu
sambucu
formosananakai
extract
exhibit
low
cytotox
markedli
decreas
cytopath
effect
arrest
cell
associ
viru
yield
reduct
concentrationdepend
manner
fig
tabl
moreov
sambucu
formosananakai
extract
show
potent
antivir
activ
valu
low
microgml
rang
ic
viru
yield
ic
fig
effect
caffeic
acid
chlorogen
acid
plaqu
format
virucid
activ
viru
attach
cell
monolay
infect
simultan
treat
caffeic
acid
chlorogen
acid
h
cover
agaros
overlay
medium
co
incub
crystal
violet
stain
inhibitori
activ
caffeic
acid
chlorogen
acid
plaqu
format
accord
ratio
loss
plaqu
number
mocktreat
group
virucid
assay
caffeic
acid
chlorogen
acid
mix
pfu
incub
h
dilut
compoundviru
mixtur
examin
residu
infect
plaqu
assay
b
attach
assay
cell
monolay
infect
pfu
immedi
treat
caffeic
acid
chlorogen
acid
h
wash
overlaid
agaros
medium
day
co
incub
attach
inhibit
determin
base
residu
plaqu
c
ca
caffeic
acid
ch
chlorogen
acid
p
valu
p
valu
p
valu
compar
untreat
infect
cell
fig
inhibit
infect
human
airway
epitheli
cell
caffeic
acid
cell
infect
moi
immedi
treat
caffeic
acid
h
imag
virusinduc
cpe
effect
photograph
light
microscop
top
addit
mock
infect
infectedtr
cell
perform
use
immunofluoresc
stain
immun
sera
secondari
antibodi
alexa
fluor
antimous
igg
middl
total
cell
stain
dapi
bottom
infect
determin
accord
ratio
cell
total
cell
b
p
valu
p
valu
compar
untreat
infect
cell
plaqu
format
ic
viru
attach
result
consist
previou
report
sambucu
spp
sambucu
nigra
l
serv
antivir
properti
influenza
b
virus
herp
simplex
viru
krawitz
et
al
serkedjieva
et
al
zakayron
et
al
addit
sambucu
juic
key
recip
viru
block
factor
process
invitro
antivir
activ
mani
respiratori
viral
infect
includ
influenza
rhinoviru
b
subtyp
respiratori
syncyti
viru
parainfluenzaviru
subtyp
adenoviru
c
subtyp
fal
et
al
sambucu
nigra
l
recogn
potenti
safer
altern
treat
upper
respiratori
symptom
common
cold
influenza
hawkin
et
al
thu
sambucu
formosananakai
might
altern
medicin
herb
care
respiratori
viral
infect
especi
coronavirusassoci
common
cold
among
six
phenol
acid
constitu
sambucu
formosananakai
extract
caffeic
acid
highest
potenc
inhibitori
effect
viru
yield
plaqu
format
viru
attach
fig
tabl
caffeic
acid
also
demonstr
antivir
activ
celltyp
independ
manner
fig
addit
chlorogen
acid
gallic
acid
exhibit
antivir
activ
fig
tabl
valu
inhibit
viru
yield
chlorogen
acid
gallic
acid
respect
phenol
acid
constitu
identifi
major
compon
sambucu
formosananakai
extract
sambucu
australi
lcmsm
analys
benevid
bahiens
et
al
zhang
et
al
therefor
caffeic
acid
chlorogen
acid
gallic
acid
might
key
compon
activ
sambucu
formosananakai
extract
caffeic
acid
report
process
antivir
activ
hepat
b
c
virus
influenza
viru
herp
simplex
viru
wang
et
al
shen
et
al
tanida
et
al
utsunomiya
et
al
ikeda
et
al
langland
et
al
caffeic
acid
reduc
product
hepat
c
viru
vitro
via
initi
stage
viral
replic
tanida
et
al
antivir
mechan
caffeic
acid
hepat
c
viru
also
associ
activ
signal
pathway
product
interferon
significantli
suppress
replic
hepat
c
viru
shen
et
al
caffeic
acid
markedli
decreas
viru
yield
cytopath
effect
influenza
virusinfect
cell
particular
period
within
h
postinfect
suggest
caffeic
acid
work
earli
stage
influenza
viru
infect
utsunomiya
et
al
addit
caffeic
acid
virucid
effect
significantli
affect
product
progeni
herp
simplex
viru
bind
attach
heparan
sulfat
proteoglycan
cell
surfac
ikeda
et
al
langland
et
al
interestingli
demonstr
util
heparan
sulfat
proteoglycan
coreceptor
attach
target
cell
milewska
et
al
caffeic
acid
also
identifi
exhibit
high
inhibitori
effect
enzymat
activ
angiotensin
convert
enzym
ace
chiou
et
al
dock
studi
reveal
caffeic
acid
also
present
good
dock
score
hydrogen
bond
interact
residu
activ
site
zozimu
divya
lobo
et
al
thu
inhibitori
mechan
caffeic
acid
attach
infect
cell
might
due
caffeic
acid
directli
target
interfer
bind
interact
heparan
sulfat
proteoglycan
coreceptor
receptor
cell
surfac
chlorogen
acid
gallic
acid
also
demonstr
suppress
vitro
vivo
replic
influenza
viru
enteroviru
hepat
b
c
virus
ding
et
al
wang
et
al
et
al
goveasala
et
al
chlorogen
acid
specif
inhibit
neuraminidas
activ
influenza
virus
crucial
mechan
chlorogen
acid
block
releas
progeni
virion
infect
cell
ding
et
al
gallic
acid
serv
antioxid
capac
link
downregul
genom
rna
protein
express
hepat
c
viru
goveasala
et
al
therefor
phenol
acid
constitu
sambucu
formosana
nakai
extract
like
caffeic
acid
chlorogen
acid
gallic
acid
play
key
antivir
compon
virus
studi
demonstr
potent
activ
sambucu
formosananakai
extract
signific
reduct
viru
yield
plaqu
format
viru
attach
caffeic
acid
chlorogen
acid
gallic
acid
report
phenol
acid
constitu
sambucu
formosananakai
extract
exhibit
antivir
capac
reduc
product
progeni
particl
vitro
moreov
caffeic
acid
play
import
compon
antivir
activ
suggest
influenc
bind
coreceptor
heparan
sulfat
proteoglycan
receptor
like
sambucu
nigra
l
sambucu
formosananakai
might
process
antivir
featur
broad
spectrum
human
respiratori
coronavirus
use
develop
antivir
agent
futur
author
declar
potenti
conflict
interest
